Sutro Biopharma, Inc. ã¯ãèšåºæ®µéã®å»è¬åã®çºèŠãéçºã補é ãè¡ãäŒç€Ÿã§ããçµ±ååç¡çްèã¿ã³ãã¯è³ªåæããã³éšäœç¹ç°ççµåãã©ãããã©ãŒã XpressCF ãéããŠãããããã³èªå·±å
ç«çŸæ£ã«å¯Ÿããã¿ã³ãã¯è³ªæ²»çè¬ã®éçºã«æ³šåããŠããŸããå瀟ã®è£œååè£ã«ã¯ãå€çºæ§éªšé«è
«ããã³éããžãã³ãªã³ãè
«ã®æ£è
ã察象ã«ããæšç CD74 ãæšçãšããæäœè¬ç©è€åäœ (ADC) ã§ãã STRO-001 (第 1 çžèšåºè©Šéšäž)ãããã³åµå·£ããããã³åå®®å
èããã®æ£è
ã察象ã«èé
žå容äœã¢ã«ãã¡ãæšçãšãã ADC ã§ãã STRO-002 (第 1 çžèšåºè©Šéšäž) ããããŸããå瀟ã¯ãããããã³èªå·±å
ç«çŸæ£ã®ãµã€ãã«ã€ã³èªå°äœã«çŠç¹ãåœãŠãç ç©¶ããã°ã©ã ãéçºããããã« Merck Collaboration ãšææºããã³ã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸãããŸããå
ç«è
«çåŠã®åéã«äž»ã«çŠç¹ãåœãŠãäºéç¹ç°æ§æäœããã³/ãŸã㯠ADC ãçºèŠããã³éçºããããã« Celgene Corporation ãšææºããã³ã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸããå瀟ã¯ä»¥å㯠Fundamental Applied Biology, Inc. ãšããŠç¥ãããŠããŸãããSutro Biopharma, Inc. 㯠2003 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµãŠã¹ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã